Infant Bacterial Therapeutics


IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.

Industries

Headquarters

Stockholm, Sweden

Employees

1-10

Links


Org chart

Collapse
Anders Kronström
Chief Operating Officer
Maria Ekdahl
Chief Financial Officer
Teresa Stohm
Executive Assistant

Board & advisors



Offices